Donating One's Body to HIV Cure Research Through Canadian Medical Assistance in Dying: A Case Study
CONCLUSION: Several circumstances facilitated the patient's participation: being a single man, having time to participate, having no strong religious belief, and valuing clear, direct communication. His motivations to participate in HIV cure research were altruistic, and also an experience of working with clinical and research teams. Finally, this perspective highlights HIV cure research participant candidates' need for education about research procedures.PMID:37670698 | DOI:10.2174/1570162X21666230904150923 (Source: Current HIV Research)
Source: Current HIV Research - September 6, 2023 Category: Infectious Diseases Authors: David Lessard Bertrand Lebouch é Andr é Morneau Martin Bilodeau Ron Rosenes Justin Sanders Nicolas Chomont Patrick Keeler Karine Dub é Shari Margolese Mohammad-Ali Jenabian Christopher Power Jean-Pierre Routy Jonathan B Angel Eric A Cohen Cecilia T Cos Source Type: research
Donating One's Body to HIV Cure Research Through Canadian Medical Assistance in Dying: A Case Study
CONCLUSION: Several circumstances facilitated the patient's participation: being a single man, having time to participate, having no strong religious belief, and valuing clear, direct communication. His motivations to participate in HIV cure research were altruistic, and also an experience of working with clinical and research teams. Finally, this perspective highlights HIV cure research participant candidates' need for education about research procedures.PMID:37670698 | DOI:10.2174/1570162X21666230904150923 (Source: Current HIV Research)
Source: Current HIV Research - September 6, 2023 Category: Infectious Diseases Authors: David Lessard Bertrand Lebouch é Andr é Morneau Martin Bilodeau Ron Rosenes Justin Sanders Nicolas Chomont Patrick Keeler Karine Dub é Shari Margolese Mohammad-Ali Jenabian Christopher Power Jean-Pierre Routy Jonathan B Angel Eric A Cohen Cecilia T Cos Source Type: research
Donating One's Body to HIV Cure Research Through Canadian Medical Assistance in Dying: A Case Study
CONCLUSION: Several circumstances facilitated the patient's participation: being a single man, having time to participate, having no strong religious belief, and valuing clear, direct communication. His motivations to participate in HIV cure research were altruistic, and also an experience of working with clinical and research teams. Finally, this perspective highlights HIV cure research participant candidates' need for education about research procedures.PMID:37670698 | DOI:10.2174/1570162X21666230904150923 (Source: Current HIV Research)
Source: Current HIV Research - September 6, 2023 Category: Infectious Diseases Authors: David Lessard Bertrand Lebouch é Andr é Morneau Martin Bilodeau Ron Rosenes Justin Sanders Nicolas Chomont Patrick Keeler Karine Dub é Shari Margolese Mohammad-Ali Jenabian Christopher Power Jean-Pierre Routy Jonathan B Angel Eric A Cohen Cecilia T Cos Source Type: research
Identification of the Near Full-length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant with a Complex Genomic Structure Isolated in Hebei Province, China
CONCLUSION: The increase in CRF01_AE/CRF07_BC recombinant viruses suggests that HIV-1 has a high genetic mutation rate in Hebei, China. This highlights the need for close monitoring of HIV-1 molecular epidemiologic changes to provide accurate, up-to-date information for effective disease control.PMID:37642005 | DOI:10.2174/1570162X21666230828122711 (Source: Current HIV Research)
Source: Current HIV Research - August 29, 2023 Category: Infectious Diseases Authors: Weina An Jianru Jia Haoxi Shi Miaomiao Su Juan Meng Weiguang Fan Source Type: research
Identification of the Near Full-length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant with a Complex Genomic Structure Isolated in Hebei Province, China
CONCLUSION: The increase in CRF01_AE/CRF07_BC recombinant viruses suggests that HIV-1 has a high genetic mutation rate in Hebei, China. This highlights the need for close monitoring of HIV-1 molecular epidemiologic changes to provide accurate, up-to-date information for effective disease control.PMID:37642005 | DOI:10.2174/1570162X21666230828122711 (Source: Current HIV Research)
Source: Current HIV Research - August 29, 2023 Category: Infectious Diseases Authors: Weina An Jianru Jia Haoxi Shi Miaomiao Su Juan Meng Weiguang Fan Source Type: research
Identification of the Near Full-length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant with a Complex Genomic Structure Isolated in Hebei Province, China
CONCLUSION: The increase in CRF01_AE/CRF07_BC recombinant viruses suggests that HIV-1 has a high genetic mutation rate in Hebei, China. This highlights the need for close monitoring of HIV-1 molecular epidemiologic changes to provide accurate, up-to-date information for effective disease control.PMID:37642005 | DOI:10.2174/1570162X21666230828122711 (Source: Current HIV Research)
Source: Current HIV Research - August 29, 2023 Category: Infectious Diseases Authors: Weina An Jianru Jia Haoxi Shi Miaomiao Su Juan Meng Weiguang Fan Source Type: research
Identification of the Near Full-length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant with a Complex Genomic Structure Isolated in Hebei Province, China
CONCLUSION: The increase in CRF01_AE/CRF07_BC recombinant viruses suggests that HIV-1 has a high genetic mutation rate in Hebei, China. This highlights the need for close monitoring of HIV-1 molecular epidemiologic changes to provide accurate, up-to-date information for effective disease control.PMID:37642005 | DOI:10.2174/1570162X21666230828122711 (Source: Current HIV Research)
Source: Current HIV Research - August 29, 2023 Category: Infectious Diseases Authors: Weina An Jianru Jia Haoxi Shi Miaomiao Su Juan Meng Weiguang Fan Source Type: research
Identification of the Near Full-length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant with a Complex Genomic Structure Isolated in Hebei Province, China
CONCLUSION: The increase in CRF01_AE/CRF07_BC recombinant viruses suggests that HIV-1 has a high genetic mutation rate in Hebei, China. This highlights the need for close monitoring of HIV-1 molecular epidemiologic changes to provide accurate, up-to-date information for effective disease control.PMID:37642005 | DOI:10.2174/1570162X21666230828122711 (Source: Current HIV Research)
Source: Current HIV Research - August 29, 2023 Category: Infectious Diseases Authors: Weina An Jianru Jia Haoxi Shi Miaomiao Su Juan Meng Weiguang Fan Source Type: research
Identification of the Near Full-length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant with a Complex Genomic Structure Isolated in Hebei Province, China
CONCLUSION: The increase in CRF01_AE/CRF07_BC recombinant viruses suggests that HIV-1 has a high genetic mutation rate in Hebei, China. This highlights the need for close monitoring of HIV-1 molecular epidemiologic changes to provide accurate, up-to-date information for effective disease control.PMID:37642005 | DOI:10.2174/1570162X21666230828122711 (Source: Current HIV Research)
Source: Current HIV Research - August 29, 2023 Category: Infectious Diseases Authors: Weina An Jianru Jia Haoxi Shi Miaomiao Su Juan Meng Weiguang Fan Source Type: research
Identification of the Near Full-length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant with a Complex Genomic Structure Isolated in Hebei Province, China
CONCLUSION: The increase in CRF01_AE/CRF07_BC recombinant viruses suggests that HIV-1 has a high genetic mutation rate in Hebei, China. This highlights the need for close monitoring of HIV-1 molecular epidemiologic changes to provide accurate, up-to-date information for effective disease control.PMID:37642005 | DOI:10.2174/1570162X21666230828122711 (Source: Current HIV Research)
Source: Current HIV Research - August 29, 2023 Category: Infectious Diseases Authors: Weina An Jianru Jia Haoxi Shi Miaomiao Su Juan Meng Weiguang Fan Source Type: research
The prevalence of HLA-B*57 serotype associated with hypersensitivity reactions in the treatment of HIV infection in the Turkish population
CONCLUSION: Considering these results, it can be assumed that the prevalence of HLA-B*57:01 in Turkey is lower than 3.3%. Instead of a high-resolution HLA-B*57:01 scan in all patients starting abacavir therapy, a high-resolution HLA-B*57:01 scan might be of greater benefit in patients who are positive on a low-resolution HLA-B*57 scan.PMID:37526185 | DOI:10.2174/1570162X21666230731145350 (Source: Current HIV Research)
Source: Current HIV Research - August 1, 2023 Category: Infectious Diseases Authors: Muhammed Ali Kizmaz Abdurrahman Simsek Figen Aymak E Halis Akalin H Barbaros Oral Ferah Budak Source Type: research
The prevalence of HLA-B*57 serotype associated with hypersensitivity reactions in the treatment of HIV infection in the Turkish population
CONCLUSION: Considering these results, it can be assumed that the prevalence of HLA-B*57:01 in Turkey is lower than 3.3%. Instead of a high-resolution HLA-B*57:01 scan in all patients starting abacavir therapy, a high-resolution HLA-B*57:01 scan might be of greater benefit in patients who are positive on a low-resolution HLA-B*57 scan.PMID:37526185 | DOI:10.2174/1570162X21666230731145350 (Source: Current HIV Research)
Source: Current HIV Research - August 1, 2023 Category: Infectious Diseases Authors: Muhammed Ali Kizmaz Abdurrahman Simsek Figen Aymak E Halis Akalin H Barbaros Oral Ferah Budak Source Type: research
The prevalence of HLA-B*57 serotype associated with hypersensitivity reactions in the treatment of HIV infection in the Turkish population
CONCLUSION: Considering these results, it can be assumed that the prevalence of HLA-B*57:01 in Turkey is lower than 3.3%. Instead of a high-resolution HLA-B*57:01 scan in all patients starting abacavir therapy, a high-resolution HLA-B*57:01 scan might be of greater benefit in patients who are positive on a low-resolution HLA-B*57 scan.PMID:37526185 | DOI:10.2174/1570162X21666230731145350 (Source: Current HIV Research)
Source: Current HIV Research - August 1, 2023 Category: Infectious Diseases Authors: Muhammed Ali Kizmaz Abdurrahman Simsek Figen Aymak E Halis Akalin H Barbaros Oral Ferah Budak Source Type: research
The prevalence of HLA-B*57 serotype associated with hypersensitivity reactions in the treatment of HIV infection in the Turkish population
CONCLUSION: Considering these results, it can be assumed that the prevalence of HLA-B*57:01 in Turkey is lower than 3.3%. Instead of a high-resolution HLA-B*57:01 scan in all patients starting abacavir therapy, a high-resolution HLA-B*57:01 scan might be of greater benefit in patients who are positive on a low-resolution HLA-B*57 scan.PMID:37526185 | DOI:10.2174/1570162X21666230731145350 (Source: Current HIV Research)
Source: Current HIV Research - August 1, 2023 Category: Infectious Diseases Authors: Muhammed Ali Kizmaz Abdurrahman Simsek Figen Aymak E Halis Akalin H Barbaros Oral Ferah Budak Source Type: research
The prevalence of HLA-B*57 serotype associated with hypersensitivity reactions in the treatment of HIV infection in the Turkish population
CONCLUSION: Considering these results, it can be assumed that the prevalence of HLA-B*57:01 in Turkey is lower than 3.3%. Instead of a high-resolution HLA-B*57:01 scan in all patients starting abacavir therapy, a high-resolution HLA-B*57:01 scan might be of greater benefit in patients who are positive on a low-resolution HLA-B*57 scan.PMID:37526185 | DOI:10.2174/1570162X21666230731145350 (Source: Current HIV Research)
Source: Current HIV Research - August 1, 2023 Category: Infectious Diseases Authors: Muhammed Ali Kizmaz Abdurrahman Simsek Figen Aymak E Halis Akalin H Barbaros Oral Ferah Budak Source Type: research
